下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemESKF-96365 hydrochlorideCat. No.: HY-100001CAS No.: 130495-35-1分式: CHClNO分量: 402.91作靶點(diǎn): TRP Channel; Autophagy作通路: Membrane Transporter/Ion Channel; Neuronal Signaling;Autophagy儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6
2、months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (248.19 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.4819 mL 12.4097 mL 24.8194 mL5 mM 0.4964 mL 2.4819 mL 4.9639 mL10 mM 0.2482 mL 1.2410 mL 2.4819 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內(nèi)實(shí)驗(yàn)請根據(jù)您的實(shí)驗(yàn)動物和給藥式選擇適當(dāng)?shù)娜芙獍福渲魄罢埾扰?/p>
3、制澄清的儲備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.20 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (6.20 mM); Clear solution3. 請依序
4、添加每種溶劑: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (6.20 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 SKF-96365 hydrochloride選擇性的TRP通道抑制劑。IC50 & Target TRP Channel 1體外研究 SKF-96365 exhibits potent anti-neoplastic activity by inducing cell-cycle arrest and
5、 apoptosis in colorectalcancer cells. SKF-96365 inhibits hERG current in a concentration-dependent manner 1. SKF-96365 caninduces cytoprotective autophagy to delay apoptosis by preventing the release of cytochrome c (cyt c) fromthe mitochondria into the cytoplasm. Mechanistically, SKF-96365 treatmen
6、t inhibits the calcium/calmodulin-dependent protein kinase II (CaMKII)/AKT signaling cascade. Overexpression of CaMKII or AKTabolishes the effects of SKF-96365 on cancer cells, suggesting a critical role of the CaMKII/AKT signalingpathway in SFK-96365-induced biological effects 2.體內(nèi)研究 SKF-96365 inhi
7、bits CRC cell growth in vivo. SKF-96365 treatment results in a decrease of p-CaMKII and p-AKT as well as an increase in LC3-II, cleaved PARP, caspase-3, and caspase-9 in mice 2.PROTOCOLAnimal Mice: Five to six-week-old female athymic BALB/c mice are inoculated into the right oxter with HCT116 cells.
8、Administration 2 When the diameter of the subcutaneous tumor reaches approximately 0.5 cm, animals are randomLyassigned to the vehicle, SKF-96365 alone, HCQ alone or SKF-96365+HCQ. SKF-96365 is applied (20mg/kg) and HCQ is applied (60 mg/kg) daily for 14 successive days by i.p. injection. Tumor size
9、s and volumeare determined. Eight mice are included in each group. Mice are sacrificed 24 h after the last treatment. Thetumors are weighed and processed for western blot analysis or paraffin embedding 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶
10、使本產(chǎn)品發(fā)表的科研獻(xiàn) FASEB J. 2019 Jun 5:fj201802550R. Acta Biochim Biophys Sin (Shanghai). 2019 Aug 5;51(8):767-777.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Liu H, et al. SKF-96365 blocks human ether-go-go-related gene potassium channels stably expressed in HEK 293 cells.Pharmaco
11、logical Research. Pharmacol Res, 2016 Feb, 104:61-9.2. Jing Z, et al. SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of thecalcium/CaMKII/AKT-mediated pathway. Cancer Lett, 2016 Mar 28, 372(2):226-38.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEMcePdfHeightCaution: Product has not
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年婚禮現(xiàn)場魔術(shù)師服務(wù)協(xié)議
- 2024年公園廣告位使用合同
- 2024年城市供水排水系統(tǒng)智能化改造合同
- 2024年市場推廣合作合同標(biāo)的
- (2024版)新材料研發(fā)與使用權(quán)轉(zhuǎn)讓合同
- 2024年廣告代理合同詳細(xì)規(guī)定
- 2(2024版)量子計(jì)算機(jī)技術(shù)開發(fā)與許可合同
- 2024年產(chǎn)品寄售合作協(xié)議
- 2024年人才引進(jìn)與獵頭合同
- 2024年區(qū)域品牌代理授權(quán)協(xié)議
- 2024年個人信用報(bào)告(個人簡版)樣本(帶水印-可編輯)
- 16J914-1 公用建筑衛(wèi)生間
- 2024年廣東恒健投資控股有限公司招聘筆試參考題庫含答案解析
- 對排球大力跳發(fā)球失誤的技術(shù)原因分析
- 中藥飲片甲類
- SH/T3903-石油化工建設(shè)工程項(xiàng)目監(jiān)理規(guī)范(承包單位用表)
- 初中化學(xué)儀器與藥品編碼
- 建筑垃圾綜合處理廠項(xiàng)目可行性研究報(bào)告(完整版)
- 《職工基本養(yǎng)老保險(xiǎn)繳費(fèi)流水情況范本表格》
- 醫(yī)院臨床帶教指導(dǎo)教師考核細(xì)則(完整版)
- 防靜電檢測方法
評論
0/150
提交評論